Cytosorbents (CTSO) Other Non-Current Liabilities (2014 - 2017)
Cytosorbents' (CTSO) quarterly Other Non-Current Liabilities came in at $1.0 million in Q2 2017, down 42.13% YoY from $1.8 million in Q2 2016, and down 37.14% on a QoQ basis from $1.7 million in Q1 2017.
Cytosorbents (CTSO) Other Non-Current Liabilities (2014 - 2017) Analysis & Trends
Cytosorbents (CTSO) has 4 years of Other Non-Current Liabilities data on file, last reported at $1.0 million in Q2 2017.
- Quarterly Other Non-Current Liabilities fell 42.13% year-over-year to $1.0 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.0 million (down 42.13% YoY) and the FY2016 annual result came in at $1.8 million, up 10.72% from the prior year.
- Other Non-Current Liabilities eased to $1.0 million in Q2 2017, from $1.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $3.0 million in Q4 2014 to a low of $1.0 million in Q2 2017.
- A 4-year average of $1.9 million and a median of $1.7 million in 2016 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2015 — Other Non-Current Liabilities tumbled 45.12% — and 2016, when it rose 10.72%.
- Tracing CTSO's Other Non-Current Liabilities over 4 years: stood at $3.0 million in 2014, then plunged by 45.12% to $1.6 million in 2015, then climbed by 10.72% to $1.8 million in 2016, then plunged by 42.23% to $1.0 million in 2017.
- The last three Other Non-Current Liabilities figures came in at $1.0 million (Q2 2017), $1.7 million (Q1 2017), and $1.8 million (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 1.05 Mn |
| Mar 31, 2017 | 1.66 Mn |
| Dec 31, 2016 | 1.81 Mn |
| Sep 30, 2016 | 2.30 Mn |
| Jun 30, 2016 | 1.81 Mn |
| Mar 31, 2016 | 1.62 Mn |
| Dec 31, 2015 | 1.64 Mn |
| Dec 31, 2014 | 2.98 Mn |